Scinai Immunotherapeutics (SCNI) Debt Ratio (2018 - 2026)

Scinai Immunotherapeutics (SCNI) has 9 years of Debt Ratio data on file, last reported at 0.04 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (changed N/A YoY), and the FY2025 full-year result was 0.05, up 5.36% from the prior year.
• Debt Ratio slipped to 0.04 in Q1 2026, from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.36 in Q2 2024 to a low of 0.04 in Q1 2026.
• A 5-year average of 0.66 and a median of 0.78 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio jumped 77.2% in 2023 and plunged 95.5% in 2024, its largest moves.
• Tracing SCNI's Debt Ratio over 5 years: stood at 0.76 in 2022, then soared by 49.62% to 1.13 in 2023, then sank by 95.5% to 0.05 in 2024, then rose by 5.36% to 0.05 in 2025, then tumbled by 31.99% to 0.04 in 2026.
• Business Quant data shows SCNI's Debt Ratio at 0.04 in Q1 2026, 0.05 in Q4 2025, and 0.07 in Q2 2025.